Cargando…
Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first–third waves with the fourth wave
BACKGROUND: The fourth wave of COVID-19 in Osaka Prefecture, Japan, caused a medical crisis. Here, we aim to identify the risk factors for COVID-19 severity and compare patients between the first–third waves and the fourth wave. METHODS: We performed an observational retrospective study of COVID-19...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Respiratory Society. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429365/ https://www.ncbi.nlm.nih.gov/pubmed/34565716 http://dx.doi.org/10.1016/j.resinv.2021.08.005 |
_version_ | 1783750515622936576 |
---|---|
author | Kurahara, Yu Kobayashi, Takehiko Shintani, Sayoko Matsuda, Yoshinobu Tamiya, Akihiro Sugawara, Reiko Arai, Toru Tachibana, Kazunobu Okishio, Kyoichi Matsui, Hideo Tsuyuguchi, Kazunari |
author_facet | Kurahara, Yu Kobayashi, Takehiko Shintani, Sayoko Matsuda, Yoshinobu Tamiya, Akihiro Sugawara, Reiko Arai, Toru Tachibana, Kazunobu Okishio, Kyoichi Matsui, Hideo Tsuyuguchi, Kazunari |
author_sort | Kurahara, Yu |
collection | PubMed |
description | BACKGROUND: The fourth wave of COVID-19 in Osaka Prefecture, Japan, caused a medical crisis. Here, we aim to identify the risk factors for COVID-19 severity and compare patients between the first–third waves and the fourth wave. METHODS: We performed an observational retrospective study of COVID-19 cases at the National Hospital Organization Kinki-Chuo Chest Medical Center. RESULTS: We identified 404 patients (median age: 71.0 years [interquartile range: 56.0–80.0]), of whom 199 (49.1%) had mild disease, 142 (35.2%) had moderate disease, and 63 (15.6%) had severe disease. The overall mortality rate was 5.4% (22/404). Based on multivariate logistic regression analysis, cardiovascular disease, fever, dyspnea, and several inflammatory biomarkers were independent risk factors for moderate to severe disease. For every 1 mg/dL increase in C-reactive protein, 10 IU/L increase in lactate dehydrogenase, and 100 ng/mL increase in ferritin, the risk for moderate to severe disease increased by 18.3%, 12.9%, and 8.9%, respectively. Overall disease severity in the fourth wave was higher than in the first–third waves. However, there was no significant difference in mortality. Because of a shortage of beds, four of the 28 severe patients (14.3%) in the fourth wave could not be transferred to the advanced hospital. CONCLUSIONS: Cardiovascular disease, fever, dyspnea, and several inflammatory biomarkers were risk factors for moderate to severe COVID-19 in our cohort. During the fourth wave, COVID-19 severity worsened, increasing the number of patients who could not be transferred to beds for severe cases, resulting in a medical crisis in Osaka. |
format | Online Article Text |
id | pubmed-8429365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Japanese Respiratory Society. Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84293652021-09-10 Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first–third waves with the fourth wave Kurahara, Yu Kobayashi, Takehiko Shintani, Sayoko Matsuda, Yoshinobu Tamiya, Akihiro Sugawara, Reiko Arai, Toru Tachibana, Kazunobu Okishio, Kyoichi Matsui, Hideo Tsuyuguchi, Kazunari Respir Investig Original Article BACKGROUND: The fourth wave of COVID-19 in Osaka Prefecture, Japan, caused a medical crisis. Here, we aim to identify the risk factors for COVID-19 severity and compare patients between the first–third waves and the fourth wave. METHODS: We performed an observational retrospective study of COVID-19 cases at the National Hospital Organization Kinki-Chuo Chest Medical Center. RESULTS: We identified 404 patients (median age: 71.0 years [interquartile range: 56.0–80.0]), of whom 199 (49.1%) had mild disease, 142 (35.2%) had moderate disease, and 63 (15.6%) had severe disease. The overall mortality rate was 5.4% (22/404). Based on multivariate logistic regression analysis, cardiovascular disease, fever, dyspnea, and several inflammatory biomarkers were independent risk factors for moderate to severe disease. For every 1 mg/dL increase in C-reactive protein, 10 IU/L increase in lactate dehydrogenase, and 100 ng/mL increase in ferritin, the risk for moderate to severe disease increased by 18.3%, 12.9%, and 8.9%, respectively. Overall disease severity in the fourth wave was higher than in the first–third waves. However, there was no significant difference in mortality. Because of a shortage of beds, four of the 28 severe patients (14.3%) in the fourth wave could not be transferred to the advanced hospital. CONCLUSIONS: Cardiovascular disease, fever, dyspnea, and several inflammatory biomarkers were risk factors for moderate to severe COVID-19 in our cohort. During the fourth wave, COVID-19 severity worsened, increasing the number of patients who could not be transferred to beds for severe cases, resulting in a medical crisis in Osaka. The Japanese Respiratory Society. Published by Elsevier B.V. 2021-11 2021-09-10 /pmc/articles/PMC8429365/ /pubmed/34565716 http://dx.doi.org/10.1016/j.resinv.2021.08.005 Text en © 2021 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Kurahara, Yu Kobayashi, Takehiko Shintani, Sayoko Matsuda, Yoshinobu Tamiya, Akihiro Sugawara, Reiko Arai, Toru Tachibana, Kazunobu Okishio, Kyoichi Matsui, Hideo Tsuyuguchi, Kazunari Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first–third waves with the fourth wave |
title | Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first–third waves with the fourth wave |
title_full | Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first–third waves with the fourth wave |
title_fullStr | Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first–third waves with the fourth wave |
title_full_unstemmed | Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first–third waves with the fourth wave |
title_short | Clinical characteristics of COVID-19 in Osaka, Japan: Comparison of the first–third waves with the fourth wave |
title_sort | clinical characteristics of covid-19 in osaka, japan: comparison of the first–third waves with the fourth wave |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429365/ https://www.ncbi.nlm.nih.gov/pubmed/34565716 http://dx.doi.org/10.1016/j.resinv.2021.08.005 |
work_keys_str_mv | AT kuraharayu clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave AT kobayashitakehiko clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave AT shintanisayoko clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave AT matsudayoshinobu clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave AT tamiyaakihiro clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave AT sugawarareiko clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave AT araitoru clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave AT tachibanakazunobu clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave AT okishiokyoichi clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave AT matsuihideo clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave AT tsuyuguchikazunari clinicalcharacteristicsofcovid19inosakajapancomparisonofthefirstthirdwaveswiththefourthwave |